ArticleProceedings (Baylor University. Medical Center)2025
Hepatitis C virus-related hepatocellular carcinoma mortality: a focus on the US-Mexico border region.
Article in Proceedings (Baylor University. Medical Center), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biological Activity of Stilbenoids Against Fungal, Parasitic, and Viral Pathogens.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the United States, hepatocellular carcinoma (HCC) mortality is disproportionately high in the US-Mexico border region. This study examined disparities in hepatitis C virus (HCV)-related HCC mortality between border and nonborder regions. Methods: We queried the CDC WONDER Multiple Cause of Death database from 2000 to 2020 for deaths with ICD-10 codes B18.2 (chronic HCV) and C22.0 (HCC). Age-standardized mortality rates (ASMRs) per 100,000 were compared across border and nonborder regions. Significant differences were determined by nonoverlapping 95% confidence intervals. Results: The border region had a 1.6-fold higher overall ASMR (95% CI = 1.5-1.7) than nonborder regions (0.8 vs 0.5 per 100,000). All ethnic groups in the border region had a higher ASMR than their nonborder counterparts, with pronounced risk ratios (RR) in White (RR = 2.0, 95% CI = 1.9-2.1), American Indian (RR = 1.9, 95% CI = 1.2-2.8), and Black/African American (RR = 1.6, 95% CI = 1.3-2.0) people. Within the border region, Black people had the highest risk compared to White people (RR = 2.0, 95% CI = 1.6-2.6), followed by American Indian people (RR = 1.6, 95% CI = 1.1-2.5). Hispanic people also had an increased risk (RR = 1.3, 95% CI = 1.2-1.4) compared to non-Hispanic people. Conclusion: HCV-related HCC mortality is significantly higher in the US-Mexico border region, particularly among Black and American Indian/Alaska Native populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.